Eric Rowinsky, CMO at Stemline Therapeutics, holds 20.63K shares in Biogen (Ticker: BIIB), holds 2.00K shares in Verastem (Ticker: VSTM), holds 68.80K shares in Fortress Biotech (Ticker: FBIO). Most recently, Eric Rowinsky Bought ― shares of Biogen on Feb 20, 2024 for an estimated value of 101.26K.